Seeking Alpha

SRPT
  Sarepta Therapeutics, Inc. - NASDAQ

8/22/2014, 4:18 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
SRPT vs. ETF Alternatives
Company Description
Sarepta Therapeutics Inc discovers and develops RNA-based therapeutics for the treatment of rare and infectious diseases. Its product candidates include eteplirsen, AVI-6002, AVI-6003, and AVI-7100.
Sector: Healthcare
Industry: Biotechnology
Country: United States